798
Views
0
CrossRef citations to date
0
Altmetric
Article

Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk

, , ORCID Icon, & ORCID Icon
Pages 336-341 | Received 26 Oct 2021, Accepted 27 Jul 2022, Published online: 08 Aug 2022

References

  • Gravas S, Cornu JN, Gacci M, EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO), et al. 2020. European association of urology guidelines 2020 edition. Presented at the EAU annual congress amsterdam 2020. Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2020.
  • Parsons JK, Dahm P, Kohler TS, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. J Urol. 2020;204(4):799–804.
  • Stenmark F, Brudin L, Stranne J, et al. High-energy feedback microwave thermotherapy and intraprostatic injections of mepivacaine and adrenaline: an evaluation of calculated cell kill accuracy and responder rate. Scand J Urol. 2014;48(4):374–378.
  • Shim SR, Kanhai KJ, Ko YM, et al. Efficacy and safety of prostatic arterial embolization: Systematic review with Meta-Analysis and Meta-Regression. J Urol. 2017;197(2):465–479.
  • McVary KT, Rogers T, Roehrborn CG. Rezum water vapor thermal therapy for lower urinary tract symptoms associated With benign prostatic hyperplasia: 4-Year results From randomized controlled study. Urology. 2019;126:171–179.
  • Bozzini G, Berti L, Aydoğan TB, et al. A prospective multicenter randomized comparison between holmium laser enucleation of the prostate (HoLEP) and thulium laser enucleation of the prostate (ThuLEP). World J Urol. 2021;39(7):2375–2382.
  • Thomas JA, Tubaro A, Barber N, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: Two-yr outcomes of the GOLIATH study. Eur Urol. 2016;69(1):94–102.
  • Huidobro C, Bolmsjo M, Larson T, et al. Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J Urol. 2004;171(2 Pt 1):672–678.
  • Bolmsjo M, Sturesson C, Wagrell L, et al. Optimizing transurethral microwave thermotherapy: a model for studying power, blood flow, temperature variations and tissue destruction. Br J Urol. 1998;81(6):811–816.
  • Schelin S. Mediating transurethral microwave thermotherapy by intraprostatic and periprostatic injections of mepivacaine epinephrine: effects on treatment time, energy consumption, and patient comfort. J Endourol. 2002;16(2):117–121.
  • Schelin S. Transurethral resection of the prostate after intraprostatic injections of mepivacain epinephrine: a preliminary communication. Scand J Urol Nephrol. 2009;43(1):63–67.
  • Stenmark F, Brudin L, Kjolhede H, et al. Prostate volume and age are predictors of energy delivery using the CoreTherm concept in patients with LUTS/BPO: a study on thermal dose. Scand J Urol. 2020;54(3):248–252.
  • Verhamme KMC, Dieleman JP, van Wijk MAM, et al. Low incidence of acute urinary retention in the general male population: the triumph project. Eur Urol. 2005;47(4):494–498.
  • Aagaard MF, Niebuhr MH, Jacobsen JD, et al. Transurethral microwave thermotherapy treatment of chronic urinary retention in patients unsuitable for surgery. Scand J Urol. 2014;48(3):290–294.
  • Schelin S, Geertsen U, Walter S, et al. Feedback microwave thermotherapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study. Urology. 2006;68(4):795–799.
  • Barry MJ, Fowler FJ, Jr., O’Leary MP, The Measurement Committee of the American Urological Association, et al. The American urological association symptom index for benign prostatic hyperplasia. The measurement committee of the American urological association. J Urol. 1992;148(5 Part 1):1549–1557.
  • Barry MJ, Fowler FJ, Jr., O’Leary MP, The Measurement Committee of the American Urological Association, et al. Correlation of the American urological association symptom index with self-administered versions of the Madsen-Iversen, boyarsky and Maine medical assessment program symptom indexes. Measurement committee of the American urological association. J Urol. 1992;148(5 Part 1):1558–1563.
  • Drake MJ, Lewis AL, Young GJ, et al. Diagnostic assessment of lower urinary tract symptoms in men Considering prostate surgery: a noninferiority randomised controlled trial of urodynamics in 26 hospitals. Eur Urol. 2020;78(5):701–710.
  • Malde S, Sahai A, Solomon ER, et al. Diagnostic assessment of lower urinary tract symptoms in men Considering prostate surgery: a noninferiority randomised controlled trial of urodynamics in 26 hospitals. Eur urol 2020;78:701-10. Eur Urol. 2020;78(6):e232–e3.
  • Sagen E, Nelzen O, Peeker R. Transurethral resection of the prostate: fate of the non-responders. Scand J Urol. 2020;54(5):443–448.
  • Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53(1):160–166.